Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2002
08/13/2002US6432644 Diagnosing polymorphism in humans
08/13/2002US6432642 Binary probe and clamp composition and methods for a target hybridization detection
08/13/2002US6432636 Detection and quantitation of splice perlecan domain gene
08/13/2002US6432633 Sandwich immunoassay method for hiv antigen and polyclonal antibodies
08/13/2002US6432632 Fluorescence polarization method
08/13/2002US6432630 Flow channel for particle separation with apertures and positioning
08/13/2002US6432629 Self assembly of sensor membranes
08/13/2002US6432412 Active immunization using a siderophore receptor protein
08/13/2002US6432409 Hybrid peptides modulate the immune response
08/13/2002US6432404 Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies
08/13/2002US6432397 Upon hydrolysis, releases conjugates of nonpeptidic polymers and biologically active molecules with an amino group; peg and protein conjugates released in vivo; peg has at least one hydrolytically unstable linkage in its backbone, such as ester
08/13/2002US6432362 Chemical sensor and coating for same
08/13/2002US6432360 Replica amplification of nucleic acid arrays
08/13/2002US6432097 Disposable absorbent articles having translational operative members
08/13/2002US6432052 health examination card for family use and it's interpreter
08/13/2002US6431748 Method and apparatus for the nondestructive determination of the purity of a test object
08/13/2002US6431016 Apparatus and methods for gas sampling
08/13/2002US6431006 Soil testing assemblies
08/13/2002CA2371519A1 Method of selecting wood for chemical pulping
08/13/2002CA2228265C Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
08/13/2002CA2202513C Allosteric modulators of the nmda receptor
08/13/2002CA2045594C Immunogenic compositions against gastrin peptides
08/13/2002CA2044591C Detection of a nucleic acid sequence or a change therein
08/13/2002CA2023354C Method for direct chemical binding of d-dimer from a biological sample for diagnosing and monitoring thrombolytic and hypercoagulable states
08/13/2002CA2019671C Oxidative denaturation of protein analytes
08/13/2002CA1341382C Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
08/12/2002CA2369893A1 Vegf responsive cell-based assay for determining vegf bioactivity
08/08/2002WO2002061661A2 Methods for determining protein and peptide terminal sequences
08/08/2002WO2002061646A1 Method and system for accepting order of manufacturing dna chip
08/08/2002WO2002061437A2 Method and system for diagnosing andropause in males
08/08/2002WO2002061436A1 Methods and devices for quantitation of glycated protein
08/08/2002WO2002061435A2 Subunit vaccines with a2 supermotifs
08/08/2002WO2002061434A2 Anergy-regulated molecules
08/08/2002WO2002061433A1 Identification of active substances against diseases associated with specific proteins
08/08/2002WO2002061432A2 Gpr22, a g protein-coupled receptor (gpcr) and compositions and methods related thereto
08/08/2002WO2002061431A2 Screening assay for modulators of syntaxin-sulfonylurea receptor binding
08/08/2002WO2002061430A2 Methods and reagents for treating autoimmune disorders
08/08/2002WO2002061429A2 A label-free high-throughput optical technique for detecting biomolecular interactions
08/08/2002WO2002061428A2 Method of disrupting interactions between biotin and biotin-binding compounds
08/08/2002WO2002061427A1 Method of analysing granular composition by fluorescence analysis
08/08/2002WO2002061426A1 Hybridized array analysis aiding method and analysis aiding device
08/08/2002WO2002061425A2 Diagnostic method and apparatus for detecting biogenic amines
08/08/2002WO2002061424A2 Organ system microarrays
08/08/2002WO2002061423A2 Identification of individual cells during kinetic assays
08/08/2002WO2002061422A1 Method for measuring antioxidative activity of cell
08/08/2002WO2002061421A2 Screening method for identifying medicaments
08/08/2002WO2002061420A2 Vitro in a cell interaction culture system for testing and developing medicaments
08/08/2002WO2002061418A1 Method of screening prion disease infection factor
08/08/2002WO2002061417A2 Chemical or biological attack detection and mitigation system
08/08/2002WO2002061415A1 Designs of labels for detection with a surface-selective nonlinear optical technique
08/08/2002WO2002061412A2 Electromagnetic analysis of concrete tensioning strands
08/08/2002WO2002061411A1 Potentiometric methods used in particular for on-site analysis of water quality
08/08/2002WO2002061409A2 Mass spectrometric analysis of complex mixtures of immune system modulators
08/08/2002WO2002061406A1 Improved affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications
08/08/2002WO2002061404A1 Method for assessing remaining useful life and overall quality of laminating paper
08/08/2002WO2002061392A2 Method and apparatus for the confinement of materials in a micromachined chemical sensor array
08/08/2002WO2002061387A2 Open substrate platforms suitable for analysis of biomolecules
08/08/2002WO2002061386A2 Marker for roscovitine
08/08/2002WO2002061239A1 Method to evaluate the hydrocarbon potential of sedimentary basins from fluid inclusions
08/08/2002WO2002061203A2 Method and apparatus for measuring paper web formation
08/08/2002WO2002061148A2 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma
08/08/2002WO2002061144A2 Brain tumor diagnosis and outcome prediction
08/08/2002WO2002061138A1 Methods for detection of chloral hydrate in dichloroacetic acid
08/08/2002WO2002061134A2 Reagents and methods for identifying and modulating expression of tumor senescence genes
08/08/2002WO2002061130A2 Methods and reagents for analysis of rna structure and function
08/08/2002WO2002061129A2 Oligonucleotide identifiers
08/08/2002WO2002061128A2 Method of determining a chemotherapeutic regimen based on ercc1 expression
08/08/2002WO2002061127A2 Arrayed polynucleotides and their use in genome analysis
08/08/2002WO2002061126A2 The preparation of polynucleotide arrays
08/08/2002WO2002061121A2 Methods of analysis of nucleic acids
08/08/2002WO2002061120A1 Method of evaluating ability of drug to induce enzyme in liver cells
08/08/2002WO2002061119A1 Compositions for assaying glycoprotein
08/08/2002WO2002061117A1 Detection and identification of groups of bacteria
08/08/2002WO2002061116A1 In vivo screening array
08/08/2002WO2002061114A2 Water-soluble, fluorescent and mobile peptide substrates
08/08/2002WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002WO2002061096A1 Determination of hydrophobic coenzyme a esters and other lipids using a biosens or comprising a modified coenzyme a- and acyl- binding protein (acbp)
08/08/2002WO2002061095A1 Novel protein and dna thereof
08/08/2002WO2002061089A2 Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same
08/08/2002WO2002061087A2 Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
08/08/2002WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002WO2002061084A2 Nt69, a nucleoside transporter family member and uses therefor
08/08/2002WO2002061083A1 Novel g protein-coupled receptor protein and dna thereof
08/08/2002WO2002061076A1 Adiponectin-associated protein
08/08/2002WO2002061075A1 Novel g protein-coupled receptor protein and dna thereof
08/08/2002WO2002061074A1 Novel protein and dna thereof
08/08/2002WO2002061073A2 Mutwnt fish for genetic screebibg of lipid and cholesterol metabolism
08/08/2002WO2002061069A1 Runx3 gene showing anti-tumor activity and use thereof
08/08/2002WO2002061061A2 Inhibition of interleukin-1-beta secretion by card proteins
08/08/2002WO2002061057A2 Regulation of human wee1-like serine/threonine protein kinase
08/08/2002WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/08/2002WO2002061051A1 Solid culture medium and method for preparing the same
08/08/2002WO2002061048A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
08/08/2002WO2002061047A2 Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry
08/08/2002WO2002061046A2 Novel nucleic acid and polypeptide molecules
08/08/2002WO2002061045A2 Simplified method for indexing and determining the relative concentration of expressed messenger rnas
08/08/2002WO2002061041A2 Solubility reporter gene constructs
08/08/2002WO2002061038A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
08/08/2002WO2002061034A2 Compositions and methods for rapidly generating recombinant nucleic acid molecules
08/08/2002WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy